Back
Tourmaline Bio, Inc. 10K Form
Sell
33
TRML
Tourmaline Bio, Inc.
Last Price:
$47.98
Seasonality Move:
28.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TRML News And Ratings
See the #1 stock for the next 7 days that we like better than TRML
TRML Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-20.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $10.09 |
| Price / Book: | 4.76 |
Profitability
| EPS (TTM): | -3.43000 |
|---|---|
| Net Income (TTM): | $-88.5M |
| Gross Margin: | $-39K |
| Return on Equity: | -29.52% |
| Return on Assets: | -28.74% |
Tourmaline Bio, Inc. Earnings Forecast
Key Tourmaline Bio, Inc. Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 3 years.
Tourmaline Bio, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Current Symbol: | TRML |
| Website: | tourmalinebio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 24.68 |
| Quick Ratio: | 23.7 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TRML Technical Analysis vs Fundamental Analysis
Sell
33
Tourmaline Bio, Inc. (TRML)
is a Sell
Is Tourmaline Bio, Inc. a Buy or a Sell?
-
Tourmaline Bio, Inc. stock is rated a SellThe current Tourmaline Bio, Inc. [TRML] share price is $47.98. The Score for TRML is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.